HEPAPOIETIN

Serial Number 78113626
601

Registration Progress

Application Filed
Mar 8, 2002
Under Examination
May 27, 2003
Approved for Publication
Feb 12, 2003
Published for Opposition
Mar 4, 2003
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: HEPAPOIETIN
Previous Owner: DAIICHI PHARMACEUTICAL CO., LTD.
Classes: 005

Trademark Image

HEPAPOIETIN

Basic Information

Serial Number
78113626
Filing Date
March 8, 2002
Published for Opposition
March 4, 2003
Abandonment Date
July 25, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Jul 25, 2003
Classes
005

Rights Holder

DAIICHI PHARMACEUTICAL CO., LTD.

03
Address
14-10 Nihonbashi 3-chome, Chuo-ku
Tokyo
JP

Ownership History

DAIICHI PHARMACEUTICAL CO., LTD.

Original Applicant
03
Tokyo JP

DAIICHI PHARMACEUTICAL CO., LTD.

Owner at Publication
03
Tokyo JP

Legal Representation

Attorney
Jess M. Collen

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

11 events
Date Code Type Description Documents
Jul 25, 2003 ABN1 S ABANDONMENT - EXPRESS MAILED Loading...
Jul 28, 2003 MAIL I PAPER RECEIVED Loading...
May 27, 2003 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2003 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 12, 2003 NPUB O NOTICE OF PUBLICATION Loading...
Dec 27, 2002 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 5, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 5, 2002 MAIL I PAPER RECEIVED Loading...
Jul 17, 2002 CNRT F NON-FINAL ACTION MAILED Loading...
Jul 12, 2002 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 24, 2002 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of diseases relating to hepatic disorders, renal disorders, multiple organ failures, metabolic disorders, blood disorders, ischemic disorders, side effects from drug and/or X-ray treatment and organ transplantation
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005